General Information of the Compound
| Compound ID |
CP0035649
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-N-benzene-1,3,4-thiadiazole-2,5-disulfonamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
1,3,4-Thiadiazole-2-sulfonamide, 5-((phenylsulfonyl)amino)-
1,3,4-Thiadiazole-2-sulfonamide, 5-[(phenylsulfonyl)amino]-
2-(Phenylsulfonylamino)-1,3,4-thiadiazole-5-sulfonamide
2-benzenesulfonamido-1,3,4-thiadiazole-5-sulfonamide
3368-13-6
3d8w
3dbu
5-(phenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide
5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide
5-benzenesulfonamido-1,3,4-thiadiazol-2-sulfonamide
AC1L2CTC
BENZOLAMIDE
Benzolamide (BZA)
CHEMBL73962
CL 11366
D8W
FC5AAH89R5
UNII-FC5AAH89R5
W 1803
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C8H8N4O4S3
|
||||||||||||||||||
| Molecular Weight |
320.377
|
||||||||||||||||||
| Canonical SMILES |
NS(=O)(=O)c1nnc(NS(=O)(=O)c2ccccc2)s1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C8H8N4O4S3/c9-18(13,14)8-11-10-7(17-8)12-19(15,16)6-4-2-1-3-5-6/h1-5H,(H,10,12)(H2,9,13,14)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PWDGTQXZLNDOKS-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
3368-13-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( BENZOLAMIDE )
| Drug Name | BENZOLAMIDE | ||
|---|---|---|---|
| Target(s) | |||